Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Scientific Reports|November 20, 2024
House dust mites stimulate thymic stromal lymphopoietin production in human bronchial epithelial cells and promote airway remodeling through activation of PAR2 and ERK signaling pathwayYi-An Hsieh, Yi-Han Hsiao, Hsin-Kuo Ko, et al.Healthcare (Basel, Switzerland)|December 29, 2020
Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary FibrosisSheau-Ning Yang, Diahn-Warng Perng, Hsin-Kuo Ko, et al.Scientific Reports|October 30, 2020
Functional parameters of small airways can guide bronchodilator use in idiopathic pulmonary fibrosisPo-Wei Hu, Hsin-Kuo Ko, Kang-Cheng Su, et al.Pharmaceutics|September 8, 2019
Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical VentilationChing-Yi Liu, Hsin-Kuo Ko, James B Fink, et al.Journal of Cellular Physiology|December 16, 2014
Regulation of Cigarette Smoke Induction of IL-8 in Macrophages by AMP-activated Protein Kinase SignalingHsin-Kuo Ko, Hung-Fu Lee, An-Hsuan Lin, et al.NPJ Primary Care Respiratory Medicine|May 30, 2019
An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding studyKang-Cheng Su, Hsin-Kuo Ko, Kun-Ta Chou, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 1, 2025
The Impact of Age and Disease Entity on Small Airway Dysfunction in Obstructive Airway DiseasesYang Li, Kang-Cheng Su, Yi-Han Hsiao, et al.Journal of the Chinese Medical Association : JCMA|June 6, 2022
Potentiality of impulse oscillometry to evaluate bronchodilator reversibility in untreated adult patients with newly diagnosed asthmaYi-Han Hsiao, Yu-Jung Lin, Tien-Hsin Jeng, et al.Life Sciences|March 4, 2023
The role of transforming growth factor-β2 in cigarette smoke-induced lung inflammation and injuryHsin-Kuo Ko, Yi-Han Hsiao, Mei-Jy Jeng, et al.Journal of the Chinese Medical Association : JCMA|June 11, 2019
Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients: Exacerbation risk assessmentSheau-Ning Yang, Hsin-Kuo Ko, Yi-Han Hsiao, et al.Pageof 5